Venous thrombosis and vessel function —It is not that simple
During the past decade, major advances in the treatment of acute deep venous thrombosis (DVT) have been achieved through the availability of oral direct thrombin/anti-Xa inhibitors and additional understanding gained in the use of pharmacomechanical catheter-directed thrombolysis in iliofemoral DVT through the results of the ATTRACT (Acute venous Thrombosis: Thrombus Removal with Adjunctive Catheter-directed Thrombolysis) prospective clinical trial. During this same period, Dr Henke and his colleagues have made important contributions to our understanding of the pathogenesis of DVT and, in particular, the role of inflammation in this process.
Source: Journal of Vascular Surgery - Category: Surgery Authors: John Blebea Tags: Invited commentary Source Type: research